IS5829A - Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants - Google Patents

Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants

Info

Publication number
IS5829A
IS5829A IS5829A IS5829A IS5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A IS 5829 A IS5829 A IS 5829A
Authority
IS
Iceland
Prior art keywords
iratatoxin
peptide fragments
cholera toxin
vaccine adjuvants
vaccine
Prior art date
Application number
IS5829A
Other languages
Icelandic (is)
Inventor
Raymond Hirst Timothy
Andrew Williams Neil
Original Assignee
University Of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Bristol filed Critical University Of Bristol
Publication of IS5829A publication Critical patent/IS5829A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IS5829A 1998-09-07 2001-01-26 Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants IS5829A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9819484.8A GB9819484D0 (en) 1998-09-07 1998-09-07 Therapeutic agents
PCT/GB1999/002970 WO2000014114A1 (en) 1998-09-07 1999-09-07 Peptide fragments of cholera toxin b or enterotoxin b as vaccine adjuvants

Publications (1)

Publication Number Publication Date
IS5829A true IS5829A (en) 2001-03-07

Family

ID=10838466

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5829A IS5829A (en) 1998-09-07 2001-01-26 Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants

Country Status (19)

Country Link
EP (1) EP1109828A1 (en)
JP (1) JP2002524469A (en)
KR (1) KR20010044842A (en)
CN (1) CN1317013A (en)
AU (1) AU772015B2 (en)
BR (1) BR9913501A (en)
CA (1) CA2338384A1 (en)
CZ (1) CZ2001839A3 (en)
EA (1) EA200100314A1 (en)
GB (2) GB9819484D0 (en)
HU (1) HUP0104090A2 (en)
IL (1) IL141695A0 (en)
IS (1) IS5829A (en)
MX (1) MXPA01002387A (en)
NO (1) NO20011075L (en)
NZ (1) NZ509631A (en)
PL (1) PL346549A1 (en)
WO (1) WO2000014114A1 (en)
ZA (1) ZA200100758B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010036917A1 (en) 1995-07-05 2001-11-01 Williams Neil Andrew Therapeutic agents
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB0115382D0 (en) 2001-06-22 2001-08-15 Univ Bristol Mutant
MXPA05005528A (en) * 2002-11-26 2006-04-05 Alk Abello As Pharmaceutical allergen product.
CN104402974B (en) * 2014-12-10 2017-11-14 重庆医科大学 A kind of polypeptide with mucosal adjuvant activity and its purposes in mucosal adjuvant is prepared
WO2024121125A1 (en) * 2022-12-06 2024-06-13 Bactolife A/S Single-domain antibodies to reduce the risk of cholera infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2527445A1 (en) * 1982-05-26 1983-12-02 Centre Nat Rech Scient MEDICINAL PRODUCTS CONTAINING AT LEAST ONE SEQUENCE OF THE CHOLERIC TOXIN B1 SUBUNIT
IL69558A (en) * 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
ZA839512B (en) * 1983-12-12 1984-08-29 Scripps Clinic Res Synthetic heat-stable enterotoxin polypeptide of escherichia coli and multimers thereof
FR2636842B1 (en) * 1988-09-27 1994-06-10 Liege Universite Etat FUSION PROTEIN OF A SEQUENCE DERIVED FROM CHOLERIC TOXIN B SUBUNIT B AND A HETEROLOGOUS ANTIGEN HAVING IMMUNOGENIC PROPERTIES, RECOMBINANT NUCLEIC ACID CONTAINING VACCINE COMPOSITIONS CONTAINING NUCLEOTIDITE CODING SEQUENCE
CA2180726A1 (en) * 1994-01-27 1995-08-03 Evgeni Veniaminovic Sokurenko Receptor specific bacterial adhesins and their use
IL109519A (en) * 1994-05-03 1999-03-12 Yeda Res & Dev Vaccines for oral immunization against infecting agents
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant

Also Published As

Publication number Publication date
EP1109828A1 (en) 2001-06-27
ZA200100758B (en) 2001-07-16
WO2000014114A1 (en) 2000-03-16
CZ2001839A3 (en) 2001-08-15
GB0107375D0 (en) 2001-05-16
EA200100314A1 (en) 2001-10-22
AU772015B2 (en) 2004-04-08
IL141695A0 (en) 2002-03-10
NO20011075L (en) 2001-05-07
MXPA01002387A (en) 2002-05-08
AU5751699A (en) 2000-03-27
CA2338384A1 (en) 2000-03-16
NZ509631A (en) 2003-11-28
GB2357507A (en) 2001-06-27
JP2002524469A (en) 2002-08-06
HUP0104090A2 (en) 2002-01-28
KR20010044842A (en) 2001-06-05
PL346549A1 (en) 2002-02-11
GB9819484D0 (en) 1998-10-28
NO20011075D0 (en) 2001-03-02
BR9913501A (en) 2001-06-05
CN1317013A (en) 2001-10-10

Similar Documents

Publication Publication Date Title
NL300311I2 (en) Adjuvant systems and vaccines
NO20004758D0 (en) vaccine Composition
DE69933200D1 (en) COMBINED VACCINE COMPOSITIONS
EP1089751A4 (en) ADJUVANT THERAPY
NO20003303L (en) Vaccine
IS4661A (en) Inhaler device
NO20006191D0 (en) Vaccine
AU2001277961A1 (en) Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
DE69730092D1 (en) Photocrosslinkable silicone compositions
HUP0300099A3 (en) Vaccine for the treatment of artherosclerosis
CY2006004I1 (en) METHOD FOR SEPARATION OF ROTAI VARIANTS AND LIVE ATTENUATED ROTAI VACCINE
IS6531A (en) Methods for the preparation of clariodorphysin and clariodorphysin intermediates, essentially oxymorphic clariforomycin and preparations containing it
DK0765333T3 (en) Quillajasaponin adjuvant and vaccine formulation containing it
DZ2283A1 (en) Vaccine composition.
EP1423141A4 (en) VACCINE
DK1109574T3 (en) Vaccine against sexually transmitted diseases
FI20070041L (en) Improved vaccine for immunization against Flavivirus infections
IS5829A (en) Peptide fragments of cholera toxin B or Iratatoxin B as vaccine adjuvants
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
KR100694919B1 (en) Acetylation of Glycol 41 Fragments
NO20005599L (en) Vaccine
EE200000694A (en) Formulation of recombinant human iterferon beta-1a (IFN-β-1a)
AU2001267613A1 (en) Adjuvant composition comprising FHA protein or fragment of FHA protein in free form
HK1036807A (en) Peptide fragments os cholera toxin b or enterotoxin b as vaccine adjuvants
DK1117421T3 (en) New methods of therapeutic vaccination